Vanguard Group
APVO icon

Vanguard Group’s Aptevo Therapeutics APVO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-91,725
Closed -$16.6K 4451
2023
Q4
$16.6K Sell
91,725
-129,339
-59% -$23.4K ﹤0.01% 4458
2023
Q3
$73K Sell
221,064
-7,760
-3% -$2.56K ﹤0.01% 4375
2023
Q2
$334K Sell
228,824
-536
-0.2% -$783 ﹤0.01% 4219
2023
Q1
$467K Sell
229,360
-9,620
-4% -$19.6K ﹤0.01% 4139
2022
Q4
$554K Buy
238,980
+136
+0.1% +$316 ﹤0.01% 4070
2022
Q3
$726K Hold
238,844
﹤0.01% 4095
2022
Q2
$855K Sell
238,844
-1,975
-0.8% -$7.07K ﹤0.01% 4139
2022
Q1
$1.41M Buy
240,819
+16,337
+7% +$95.9K ﹤0.01% 4095
2021
Q4
$1.77M Buy
224,482
+89,210
+66% +$702K ﹤0.01% 4090
2021
Q3
$2.09M Buy
135,272
+512
+0.4% +$7.9K ﹤0.01% 4046
2021
Q2
$3.02M Buy
134,760
+3,830
+3% +$85.9K ﹤0.01% 3833
2021
Q1
$4M Sell
130,930
-19,772
-13% -$604K ﹤0.01% 3641
2020
Q4
$5.52M Buy
150,702
+76,240
+102% +$2.79M ﹤0.01% 3318
2020
Q3
$565K Buy
74,462
+15,301
+26% +$116K ﹤0.01% 3791
2020
Q2
$494K Sell
59,161
-1,148
-2% -$9.59K ﹤0.01% 3768
2020
Q1
$223K Sell
60,309
-806,469
-93% -$2.98M ﹤0.01% 3844
2019
Q4
$567K Sell
866,778
-3,850
-0.4% -$2.52K ﹤0.01% 3771
2019
Q3
$512K Sell
870,628
-251,510
-22% -$148K ﹤0.01% 3815
2019
Q2
$994K Sell
1,122,138
-364,427
-25% -$323K ﹤0.01% 3679
2019
Q1
$1.34M Buy
1,486,565
+756,269
+104% +$680K ﹤0.01% 3552
2018
Q4
$928K Sell
730,296
-2,915
-0.4% -$3.7K ﹤0.01% 3587
2018
Q3
$3.73M Hold
733,211
﹤0.01% 3332
2018
Q2
$3.66M Sell
733,211
-5,638
-0.8% -$28.1K ﹤0.01% 3313
2018
Q1
$2.42M Sell
738,849
-1,138
-0.2% -$3.72K ﹤0.01% 3393
2017
Q4
$3.14M Buy
739,987
+37,612
+5% +$159K ﹤0.01% 3289
2017
Q3
$1.61M Buy
702,375
+229
+0% +$524 ﹤0.01% 3468
2017
Q2
$1.45M Sell
702,146
-63,625
-8% -$132K ﹤0.01% 3477
2017
Q1
$1.58M Sell
765,771
-91,596
-11% -$189K ﹤0.01% 3459
2016
Q4
$2.09M Buy
857,367
+20,774
+2% +$50.7K ﹤0.01% 3350
2016
Q3
$2.14M Buy
+836,593
New +$2.14M ﹤0.01% 3365